Robinson James A. Jr. bought URGN
August 26, 2026 · Form 4 insider transaction
Robinson James A. Jr. bought 2,000 shares of UroGen Pharma Ltd., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,000
Price
N/A
Total value
N/A
InsiderRobinson James A. Jr.
RoleDirector
CompanyUroGen Pharma Ltd. (URGN)
Securityordinary shares
Transaction codeM: Option exercise
Transaction dateAugust 26, 2026
Filing dateAugust 28, 2026
Shares owned after8,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer